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Abstract 
Stimulation of substance P release from sensory nerves by incretin hormones 
By  
Fahima Mayer 
Doctor of Philosophy in Endocrinology 
University of California, Berkeley 
Professor Gregory W. Aponte, Chair 
 
The communication between the gut and the brain is very complex and is regulated by 
various systems, such as the endocrine, immune, autonomic, and the enteric nervous 
system.  Food intake has been known and thought to play a major role in this 
communication.  Previously the laboratory of my graduate work showed that guanine 
nucleotide-binding protein couple receptor (GPCR) GPR93 (also known as 
lysophosphatidic acid 5 (LPA5) or GPR92) is located at the apical side of the gut lumen 
and senses nutrients in the lumen of the gut.  This receptor was the first to be 
discovered to be localized on sensory nerves and yet respond to components in 
mesenteric lymph fluid (MLF) induced in response to the diet. The lymphatic fluid 
contains cells and molecules from the interstitial fluid (IF) that surrounds specific 
tissues. My study was to examine if the afferent sensory nerves that innervate the 
mesenteric lymphatic vasculature could be activated by diet induced molecules of the 
MLF to form a system of nutrient sensing of the interstitium. I observed that MLF 
stimulated primary cultured mouse dorsal root ganglia (DRG) sensory neurons. I 
discovered that Glucagon-like peptide 1 (GLP-1) or Glucose-dependent insulinotropic 
polypeptide (GIP) as model molecules of the MLF stimulated those neurons resulting in 
the release of Substance P (SP). GLP-1 and GIP are incretin hormones, which induce 
blood glucose levels to go down after a meal.  The results of this study showed a new 
mode of action for GLP1 and GIP incretin hormones that is extra-pancreatic and how 
the peripheral tissues and the central nervous system could be stimulated by molecules 
of the interstitium/MLF via afferent sensory nerves. 
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Background 
Various cultures have used different foods for their assumed and/or known effects. I 
was brought up in a culture that categorizes certain foods as “cold” or “warm,” on how 
they affect the body. In 400 B.C., the “Father of Medicine”, Hippocrates, pronounced, 
“Let thy food be thy medicine and thy medicine be thy food.” This Greek physician 
pointed to the significant impact of food on a person’s body and mind to prevent 
illnesses, to maintain health and wellbeing. The Bedouin, the people of the desert, of 
the ancient stated, “you are what you eat.” The ancients already recognized that food 
was not only for their survival but ingested food also communicated with the mind. The 
link between food and health, or how ingested food communicates with the body and 
the brain, has been investigated from a very ancient time, and still there is much left yet 
to be discovered. 
 
Nutrient Sensing 
Digestion and nutrient sensing begins at the mouth.  Even with the thought or sight of 
food saliva is secreted and with food in the mouth and chewing, the salivary glands are 
further stimulated to release more and more saliva, depending on the size of the bit and 
the strength of the chewing.  Saliva makes compounds accessible for taste by breaking 
down food (1).  After the ingestion of food various metabolic responses take place in the 
gastrointestinal (GI) tract, including the secretion of hormones.  The GI tract is the 
largest endocrine organ of the body.  Specific mucosal responses are initiated by the 
ingested macronutrient and micronutrient components.  Micronutrients are substances 
in food that the body needs in trace amounts to function properly, such as vitamins and 
minerals.  Unlike Macronutrients, they yield no energy (2).  Macronutrients are the 
components of food, such as carbohydrates, fats, and proteins, that provide our body 
with calories or energy (3) (4).  Multiple hypotheses exist on the mechanism of 
macronutrient sensing.  Our lab previously reported that dietary macronutrients in the 
lumen of the intestine could influence what takes place in the intestinal mucosa via 
receptors.  Gastrointestinal bioactive peptides, such as cholecystokinin (CCK) and 
peptide tyrosine tyrosine (PYY), are shown to be secreted by the stimulation of 
macronutrient and subsequently activate their receptors (5).  Layer and colleagues first 
reported in 1995 on Glucagon-like peptide 1 (GLP-1) being released in the ileum in 
response to carbohydrate and lipid perfusions.  GLP-1 was previously discovered as a 
hormone that regulated gastric secretion(6) (7).  In 1998, Dumoulin and colleagues 
published on the release of peptide hormones, including PYY, GLP-1, and neurotensin 
(NT), in response to specific nutrients being infused in the rat ileum (8).  Even before 
Dumoulin, the release of PYY was investigated by Aponte, who concluded that the 
release of the peptide hormone is not dependent on the length of the fatty acid chain 
and that the duodenum is not the major site of release of this peptide (9).   
 
PYY and other hormones of the gut play a role in what is termed the “ileal break”, which 
is the most studied and earliest discoveries on the effects macronutrients, in this case 
dietary fat, have on how the function of the intestine is regulated.  The “ileal break” is a 
negative feedback mechanism that controls the rate at which ingested food moves 
through the gut, it decreases the motility of the GI tract in response to nutrients that are  
not absorbed and decreases food intake and results in a sensation of satiety.  Very  
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effective inhibitors of gut motility and digestive enzyme secretion are long chain fatty 
acids.  This is, to some extent, because of their stimulation of regulatory 
enteroneurohormone secretion, like CCK and PYY. That occurs when the content of the 
GI lumen comes in contact with the L and N cell of the gut mucosa resulting in secretion 
of those hormones. This is how the ileal brake is thought to regulate digestion and 
absorption of food (10) (11).  
 
The mechanism of macronutrient sensing was first reported by the discovery of nutrient-
sensing G protein coupled receptors (GPCRs), which were shown to be localized at the 
brush border enteroendocrine cell plasma membranes.  And conveniently they were 
shown to face into the gut lumen allowing them to be stimulated by post-prandial luminal 
contents, such as peptide hormones (11) (12) (13) (14) (15).  
 
Nutrient sensing GPCR 
In the last decade, various seven transmembrane receptors have been identified and 
characterized that sense organic nutrients. The ligands for such receptors include 
amino acids (taste1 receptor T1R1/T1R3), proteolytic degradation products (GPR93, 
also termed GPR92), carbohydrates (T1R2/T1R3 receptor), and free fatty acids (FFA1, 
FFA2, FFA3, GPR84, and GPR120).  They are expressed in a variety of tissues, such 
as taste tissue, the gastrointestinal tract, endocrine glands, adipose tissue, and the 
kidney.  These receptors have the ability to act as sensors of food intake and function in 
regulating the release of incretins and other hormones from the gut, insulin and 
glucagon from the pancreas, and leptin from adipose tissue (16).  
GPCR                                                                                                                            
GPCRs account for a large and diverse family of cell surface proteins that are present in 
the GI tract, taste tissues, endocrine glands, adipose tissues, kidney and others.  There 
are more than 800 GPCRs found in humans, which fall into the following five classes: 
rhodopsin (Class A), secretin (Class B), glutamate (Class C), adhesion (Class D), and 
frizzled/smoothened (Class E) (17) (18,Devi, 2005 #90).  GPCRs are comprised of 
seven transmembrane domains, in addition to an external amino terminal fragment, 
which interacts with a ligand, and an internal carboxy terminal end, which interacts with 
the intracellular G protein.  They are significant molecules in our sense of smell, taste, 
touch, and vision (10).  
They sense signals in their extracellular environment and transmit these to their 
appropriate intracellular heterotrimeric G proteins. When these G proteins are in their 
GDP containing heterotrimeric state, they are inactive.  They become active when the 
heterotrimeric protein, Gαβγ, separates into the active Gα and Gβγ dimer subunits as a 
result of nucleotide exchange, and GDP is converted to GTP by the endogenous 
GTPase activity of the G proteins. There are different groups of Gα, such as Gαq, that 
increases intracellular calcium concentrations and Gαs that enhances cAMP generation. 
There are various different cascades that are induced by the downstream effects of the 
ligand interaction, and the activation of the Gα protein and the Gβ/Gγ dimer.  Three  
most common cascades that could be activated by this are the adenylate 
cyclase/cAMP, MAPK kinase, and phospholipase C mediated pathways (19) (20) (18) 
(21) (22) (23) (24).      
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Peptide hormones and gut peptides                                                                              
A major class of hormones are classified as peptide hormones, which are ligands to all 
Class B or the rhodopsin class GPCRs, such as glucagon, parathyroid hormones, and 
calcitonin.  They serve as leading targets for drug therapies, such as for endocrine and 
neuronal disorders (17).  Peptide hormones play significant role in various in vivo 
processes, such as being important signaling molecules.  In vivo, enzymes break down 
peptides quickly, and thus they are rapidly excreted from the body.  
They are made by specialized endocrine glands, as part of a more complex large 
preprohormone, which is then proteolytically cleaved at its N-terminal signal sequence 
and results in a prohormone.  This prohormone matures, as it is transported from the 
rER to the Golgi apparatus, and finally enclosed in secretory granules to be released as 
the bioactive hormone.  As they are released into the circulation, the peptide hormones 
find their receptors located on the plasma membrane of the target cells and interact with 
them to initiate an intercellular signaling pathway that will regulate some specific 
physiological process.  A few of their target regulations may be energy metabolism, 
growth, stress, or reproduction.  Overexpression of peptide hormones are related to 
tumors and used as clinical diagnosis for monitoring their growth and disease process 
(25) (26).   
One major class of peptide hormones are the gut peptides.  The physiological 
importance of the gut peptides has been much broadened over the last decade, then 
just the gastrointestinal digestion and nutrients absorption.  Specialized cell in the 
gastrointestinal tract called enteroendocrine cells (EECs) make up around 1% of the 
total gut epithelium cell population.  They release more than 20 signaling molecules that 
have endocrine and metabolic functions. These molecules are part of the gut-brain axis 
and are able to communicate with the brain (27) (28). Many gut hormones have been 
discovered and identified as being part of the gastro-entero-pancreatic system, but the 
first being the discovery of “secretin” by Bayliss and Starling.  These gut hormones play 
a role in many metabolic disorders, such as obesity, type 2 diabetes, and others.  
Special interest has been put on the two incretin hormones, GLP-1 and Glucose-
dependent insulinotropic polypeptide (GIP), which are significant in a number of 
physiologic process, specially glucose homeostasis (29) (30).  
GLP-1                                                                                                                          
GLP-1 is an incretin hormone made in the small intestinal epithelial L-cells from 
posttranslational processing of a gene product called proglucagon.  It was first 
discovered in humans as an incretin hormone in 1987.  It is a 30 amino acid long 
peptide hormone that is secreted from these cells in response to intake of food. GLP-1 
follows the evolving idea that the synthesis of small peptide hormones take place from 
larger prohormones and that the final form of the hormone that has biological activity is 
formed by posttranslational cleavages by enzymes from the prohormones.  Earlier 
examples of such hormones include insulin and parathyroid hormones.  Furthermore, 
GLP-1 also shows liberation that is tissue specific.  Table. 1, modified from Daniel  
Drucker, depicts the location of the peptides and its tissue specific liberation.  However, 
unlike the typical bioactive peptide that follows the regular liberation process from a 
prohormone, being cleaved at sites having two basic amino acids and thus beginning 
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with histidine and having a glycine at the end, GLP-1 has a “second single basic amino 
acid followed by histidine residing 6 amino acids carboxyl-proximal to the histidine.”  
This makes GLP-1 a 31 amino acid long peptide, rather than 37, called GLP-1 (7-37).  
Moreover, a sequence RGRR, which suggests for a prohormone “convertase-directed 
cleave” site, followed by “an amidation of the penultimate arginine” via a peptidylglycine-
alpha-amidation monooxygenase takes place, which produces two peptides of 36 and 
30 amino acids long, namely GLP-1(1-36)amide and GLP-1(7-36)amide (31).  
 
  
1 GRPP  
3 IP-1  
2 Glucagon Pancreas 
(PC2) 4+5+6 MPGF 
4 
GLP-1 [GLP-1(1-37), 
GLP-1 (7-37), GLP-1 
(7-36)] 
Intestine 
(PC1) 
5 IP-2 
6 GLP-2 
2+3 Oxyntomodulin 
1+2+3 Glicentin 
 
Table 1. Human proglucagon structure and processing in human, depicting tissue 
specific liberation of each peptide derived from proglucagon in the pancreas or the 
intestine. PC1: prohormone convertase 1; PC2:  prohormone convertase 2; MPGF:  
major proglucagon fragment. Modified from: (31).   
The enzyme called dipeptidyl peptidase IV (DPP-4), inactivates GLP-1 very rapidly, not 
even allowing the hormone to leave the gut.  Thus, even though GLP-1 has important 
functions outside the gut, it is already inactivated before it has a chance to leave the 
gut.  This makes GLP-1 a possible neurotransmitter, where its actions are transmitted 
through sensory neurons in the intestine and elsewhere in the body where the GLP-1 
receptor (GLP-1R) is expressed.  Thus GLP-1 can be observed as a peptide hormone 
and a neuropeptide, having functions both as an endocrine hormone and also having 
neural actions (29) (30) (32). 
The most well-known action of GLP-1 is its action as an incretin, which is the stimulation 
of insulin secretion in response to a meal and to inhibit the secretion of glucagon, 
therefore decreasing the glucose level found in the blood after a meal. GLP-1 is also 
known function as an enterogastrone by inhibiting gastrointestinal motility and section.  
Furthermore, GLP-1 plays a physiological role in regulating appetite and food intake.  
Because of the above-mentioned actions of GLP-1, GLP-1 and GLP-1R agonists are 
used to treat type 2 diabetes.  Obesity may result when there is not enough GLP-1 
1 2 3 4 5 6 
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secreted from the L-cells, or when the enzyme, dipeptidyl peptidase IV, is overactive.  
On the other hand, postprandial reactive hypoglycemia may result if there is too much 
GLP-1 around or the activity of DPP-4 is inhibited (29) (30) (32). 
GIP                                                                                                                         
Glucose-dependent insulinotropic polypeptide (GIP) is another incretin hormone that is 
also degraded by of dipeptidyl peptidase IV.  It was first discovered in 1973 by Brown 
and collages and termed gastric inhibitory polypeptide, because they observed it as a 
polypeptide inhibitor of gastric acid secretion in dogs that received Heidenhain's 
pouches.  These pouches are small sacs that is closed off from the main cavity but with 
an opening in the abdominal wall and also vagally denervated.  They are used for 
obtaining gastric juice (33).  GIP is released from the K cells of the upper part of the 
small intestine.  It is 42 amino acids long.  Although it was first known for its inhibition of 
gastric acid, it was later discovered that GIP also stimulates the release of insulin, by 
directly acting on the islets of the pancreas in healthy individuals when administrated 
orally. Furthermore, it was found that in gastrectomized patients, endogenous GIP 
resulted in a glucose dependent release of insulin, which made it the first incretin 
hormone and thus it was renamed as glucose-dependent insulinotropic polypeptide. 
Like GLP-1, GIP also need to go through proteolytic processing of preproGIP to make 
the secreted GIP (32) (34) (35) (36) (37) (38).  These incretin hormones also have 
pancreatic and exopancreatic functions that are well summarized in Table. 2, modified 
from (39).  
 
  GLP GIP 
Brain 
↑ Memory ↑ Memory 
  ↓ Food intake 
Pancreas 
↑ Insulin ↑ Insulin 
↑ Glucagon ↓ Glucagon 
↓ Beta-cell apoptosis ↓ Beta-cell apoptosis 
↑ Beta-cell proliferation 
↑ Beta-cell 
proliferation 
GI tract ↓ Gastric acid secretion ↓ Gastric emptying 
Heart 
↑ Cardioprotection   
↑ Cardiac output   
Bone   ↑ Bone formation 
Adipose 
tissue   ↑ Fat accumulation 
 
Table 2. Illustration of the pancreatic and exopancreatic function of GIP and GLP-1.  
Modified from: (39). 
 
Previously, it has been difficult to study GLP-1 and GIP in the circulation, because of 
their low levels present in the blood and also the low sensitivity of the available 
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immunoassays.  However, in 2011, with the development of new methods, such as the 
lymph fistula rat model and the lymph duct cannulation techniques used in mice, these 
limitations were overcome and furthermore enabled scientist to follow and monitor the 
secretion of incretin continuously from the gut in response to food (40) (41).   
GLP-1 levels in the mice gut lymphatics was evaluated after glucose ingestion versus 
fat ingestion in vivo, and also with or without DPP-4 inhibition.  Lymph was collected 
every 30 minutes from the mesenteric lymphatic duct that was cannulated and 
compared to peptide plasma levels.  Treatments were administered by gastric gavage.  
It was shown that basal intact levels of GLP-1 was more than 5 times higher in lymph 
compared to plasma (0.37 pmol/l versus 0.07 pmol/l), and basal DPP-4 activity was 
about 5 times lower in lymph compared to plasma (4.7+/-0.3 pmol/min/mul versus 
22.3+/-0.9 pmol/min/mul).  Furthermore, the flow of lymph also doubled comparing 
before and after glucose and fat adminstration.  Calorie dependency was increased by 
lymph GLP-1 levels after glucose and fat ingestion, however with different patterns.  
Glucose caused a transient increase and fat, a sustained increase that was mainted 
above baseline even after 210 min.  Overall, it was illustrated that there is significantly 
less GLP-1 in plasma compared to lymph and also there is significantly less DPP-4 
activity in the lymph compared to plasma, corrlating with the increased GLP-1 
concentration (42).  
GLP and GIP’s actions are mediated by their specific receptors, GLP-1R and GIP 
receptor (GIPR).  These receptors are expressed in the central nervous system (CNS) 
as well as the peripheral nervous system (PNS), including the eyes, kidney, heart, liver, 
fat and several other organs (40).  We are interested in the receptors that are expressed 
in the sensory nerves that innervate the lymphatic lacteals of the gut.  Such nerves are 
part of the spinal nerves.   
Gut-Brain Axis                                                                                                                
The gut-brain axis has been well established through the vagus nerve, which connects 
the gastrointestinal tract and the brain and through afferent nerve fibers sending 
information about the inner organs to the brain.  In addition to such communication, we 
provide evidence that the lymphatic lacteals of the intestine are innervated by visceral 
sensory nerves that are part of the spinal afferent nerves, separate from those of the 
vagus nerve (41).  In such a system, the interstitial fluid acts as a vehicle for the 
molecules deposited there from the surrounding tissues to exert biological activity 
through these spinal afferent nerves to stimulate a specific systemic physiological 
response.  The interstitium is made from various layer, which include the interstitial fluid, 
the extracellular matrix that is present on the outside of blood and lymphatic vessels, 
and connective tissues.  Molecules from the blood capillaries, including the interstitial 
fluid, secretions from cells, and other factors from the surrounding cellular environment, 
such as metabolites, antigens and cytokines, come together into the lymphatics forming 
the lymphatic fluid.  Some factors that determine the formation of the lymphatic fluid 
include transcapillary exchange that is dependent on the hydrostatic pressure of the 
vessel, the concentration of blood protein found within the capillaries, and the 
interstitium.  One of the features that makes mesenteric lymphatic fluid special is the 
fact that it can contain molecules that come from the lumen of the intestine and are 
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exogenous in origin, in addition to gut peptides and other molecules secreted from the 
enteroendocrine cells of the intestine (43). 
 
Sensory Nerves                                                                                                            
The spinal nerves directly branch from the spinal cord and the CNS.  They are classified 
as a part of the PNS.  They are mixed nerves that come in pairs and have both sensory 
and motor fibers, and are able to transmit sensory, motor, and autonomic impulses 
going into and out of the spinal cord, to and from the rest of the body.  Thus, they 
function as intermediary fibers between the CNS and the periphery. There are a total of 
31 spinal nerves that are grouped based on their spinal region.   There are eight 
cervical nerve pairs located in the cervical region, names C1-C8, twelve thoracic nerves 
pairs located in the thoracic region, as the name suggests, and are called T1-T12, five 
lumber nerve pairs (L1-L5), and one single coccygeal nerve pair (44).  
The dorsal root, which synapses at the dorsal horn of the spinal cord, and the ventral 
root, which synapses at the ventral horn, both emerge forming the spinal nerve, from 
the posterior and anterior side, respectively.  The dorsal root, composed of afferent 
sensory axons, sends visceral and somatic sensory information from the peripheral 
receptors back to the CNS, forming the afferent sensory root of the spinal nerve. It 
travels to the dorsal root ganglia (DRG), which are oval enlargement found just outside 
the spinal cord and house the pseudo-unipolar cell bodies of the nerve fibers.  Specific 
spinal nerves are mapped to the human body in an organized way, dividing the body 
into regions, called dermatomes, which are areas of cutaneous sensory innervation by 
specific spinal nerves.  To transmit information to the spinal nerve, the DRG will 
synapse on an interneuron which is found in the cord’s gray matter as a part of the 
motor reflex arc.  To transmit sensory information to the thalamus, dorsal root fibers 
ascent through multiple pathways in the spinal cord (45) (44).    
Primary sensory neurons receive information from the external environment and then 
transmit it to the CNS.  The activation of these neurons causes the release of a variety 
of neurotransmitters, such as Substance P (SP)  and Calcitonin gene-related peptide 
(CGRP) from peripheral endings (46).  CGRP and SP are two neuropeptides that are 
significant in the process of hyperalgesia and pain.  They also play a role in migraine 
attacks, specially CGRP as a potent vasodilator, which is secreted during migraine 
attacks from sensory nerve endings (47) (48).  In the trigeminovascular system, CGRP 
is more responsible for the regulation and transmission of pain, as opposed to SP that 
enhances vascular permeability (48) (49) (50) (47).  
TRPV1 and TRPA                                                                                                           
The TRPV1 and TRPA receptors are part of the transient receptor potential (TRP) 
family, that is made up from a diverse group of cation channels, which are responsible 
for the regulation of different intracellular signaling pathways.  Based on their homology, 
the 28 mammalian TRPs are placed into 6 subfamilies, namely:  canonical (TRPC1-7), 
vanilloid (TRPV1- 6), melastatin (TRPM1-8), ankyrin (TRPA1), poly-cystin (TRPP1-3) 
and mucolipin (TRPML1-3) (51).  The most studied TRP channel is the transient 
receptor potential vanilloid 1 (TRPV1) channel, which plays an important role in 
nociception and sensory transmission and releases SP upon stimulation.  It functions as 
a nonselective and selective gate for cations, where it has 10-fold higher preference for 
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calcium when it is activated, rather than functioning nonselectively.  TRPV1 was first 
discovered in dorsal root ganglia and shown to be the receptor for capsaicin.  However, 
now the receptor is illustrated to have several significant other functions, such as being 
activated by noxious heat over 42°, pH, lipoxygenase products, and voltage; and broad 
distribution within the CNS.  TRPV1 can interact with other receptor pathways and it can 
be activated by a variety of potentially noxious stimuli.  This makes the receptor a good 
candidate for a stress response protein, regulating the function of the CNS in response 
to stress.  TRPV1 plays a major role in CNS functions by modulating glial and neuronal 
activity.  It has been shown that the receptor is involved in glial reactivity, cytokine 
release and synaptic transmission and plasticity (51) (52).  
When this calcium permeable cation channel, TRPV1, is activated, a large inward 
current is induced, which increases intercellular calcium concentration, caused by the 
influx of calcium from the intracellular compartment of primary sensory neurons.  This 
depolarization caused by the TRPV1 was illustrated to be transmitted to the CNS as 
nociceptive information through primary sensory neurons (53) (54) (55).  Bradykinin 
receptors, purinergic receptors, and glutamate receptors, are other receptors that 
regulate current responses that are mediated by TRPV1 (56) (57) (58) (59) (55).  
The transient receptor potential ankyrin 1 (TRPA1) channel is co-expressed in some 
TRPV1 expressing DRG neurons.  It is expressed in skin sensory neurons, epithelial 
cells of the intestine, lungs, urinary bladder and other places.  This cation channel 
senses thermal and mechanical stimuli and is stimulated by allyl isothiocyanates, which 
are found in mustard, wasabi, and horseradish, garlic, onion, tear gas, cinnamon, etc.  
Ligands for TRPA1 are used to treat inflammation-associated pain (60). 
Both TRPV1 and TRPA1 transmit signals to secondary neurons in the dorsal horn of the 
spinal cord and the brain by acting on neurons as primary afferent nociceptors.  When 
capsaicin binds to TRPV1 or allyl isothiocyanate (AITC) binds to TRAPA1, it triggers a 
calcium-dependent mechanism and can cause the release their stored neuropeptides 
from the stimulated peripheral nerve terminals.  This has been termed a “sensory-
effector” function of these receptors.  Calcitonin gene-related peptide and substance P 
are the most studied sensory neuropeptides that can be released by such activation of 
nerves and function as stimulators of inflammation (61).  Taking this into consideration, 
we can specualte that molecules found in the IF/MLF could stimulate such peptidergic 
sensory neurons that have receptors for these molecules contained in the MLF and 
located in the lymphatic lacteals to secrete peptides, such as SP, when stimulated.  This 
would provide additional evidence that molecules from the IF/MLF stimulate sensory 
nerves innervating the lymphtic vasculature and releasing neuropeptides as a result, 
thus signaling to the brain as part of a chemosensory system (62).  
LPA5                                                                                                                              
LPA5 expressing cells illustrated mobilization on intercellular calcium when treated with 
MLF in a time- and dose- dependent fasion.  It served as a model for GPCRs that are 
nutrient-responsive and localized on sensory nerves (62).  LPA5 modulates the 
proliferation and differentiation of mucosal cells, as well as the secretion of hormones 
from intestinal cells. It was also shown by our lab that the LPA5 receptor responded to 
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dietary products in the lumen, namely dietary protein hydrolysate (peptone).  From the 
literature, it is known that the secretion and transcription of cholecystokinin (CCK) is 
escalated by protein hydrolysate.  This lead to the idea and further discovery that LPA5 
plays a role in the stimulation of CCK expression and secretion via its protein 
hydrolysate ligand (63) (64).  A calcium-dependent release and synthesis of CCK was 
observed with the activation of LPA5 by peptone.  However, no CCK was synthesized 
for release when the receptor was activated by LPA, another ligand for LPA5.  The 
presence of peptone seems to be what regulates the secretion of CCK from the 
enteroendocrine cells (EECs) of the gut and this release is not dependent of whether 
LPA is present or not (63) (64) (65).  The expression of LPA5 is very broad.  It is 
expressed in the mucosal cells, specifically the enteroendocrine cells of the duodenal-
jejunal mucosa (64), neuronal tissue, including DRG (66) and the dorsal horns of the 
spinal cord (67). 
 
Rationale and Objectives                                                                                             
Our lab previously discovered a nutrient responsive GPCR, LPA5, that is co-expressed 
in primary cultured DRG neurons expressing CGRP and TRPV1. The characterization 
of this receptor was the first to illustrate that sensory nerves express receptors that 
respond to changes in MLF induced by the diet, and that these peptidergic nerves 
innervate lymphatic lacteals of the gut, thus coming in direct contact with MLF (62-64).   
The objective of my study was to determine if sensory nerves, similar to the nerves 
innervating the lymphatic lacteals of the gut, could be activated by MLF containing 
molecules derived from the interstitial fluid, as part of a chemosensory system of the 
interstitium.  In this system, the molecules of the MLF is reflective of the IF and contains 
endogenous as well as exogenous molecules, such as those that originate from the 
lumen of the intestine.  Such molecules could exert their biological activity and transmit 
signals through peripheral sensory nerves, to produce the appropriate physiological 
response.  Furthermore, such activity is potentially localized, as the MLF/IF contents 
depends on its surrounding tissue/organ.  Specifically, my aims are to examine the 
activation of sensory nerves by GLP-1 and GIP as models, because their concentration 
in the MLF is induced by feeding, and to investigate if sensory nerves stimulated with 
these peptide hormones would result in the release of Substance P.  
 
Experimental procedures   
Compounds.  Exendin-4 (Ex-4), a potent agonist of the glucagon-like peptide 1 (GLP-
1R), was purchased from AnaSpec.  Gastric inhibitory polypeptide (GIP) was purchased 
from Phoenix Pharmaceuticals, Inc. All other chemicals were purchased from Sigma 
Aldrich.   
  
Animals. WT mice, C57BL/6 (6–10 wk) from Jackson Laboratory, of equal number of 
males and females, were used as controls for all experiments.  Procedures were carried 
out according to the guidelines of the National Institutes of Health Animal Research and 
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were approved by Institutional Animal Care and Use Committees of the University of 
California at Berkeley and by the University of Cincinnati Institutional Animal Care and 
Use Committee. The generation and background of GLP-1R KO and GIPR KO mice on 
a C57BL/6 background used in this study were kindly provided by Dr. Daniel Drucker as 
have been previously described (68).  TRPA1 KO and TRPV1 KO were gifts from Dr. 
David Julius as described (53) (69).  TRPA1/V1double-mutant mice were generated as 
described (70).  Briefly, TRPV1–/– and TRPA1–/– animals were crossed resulting in 
TRPV1+/– TRPA1+/– progeny, which were then crossed to yield wild-type and double-
knockout siblings for analyses.  
 
Plasmid constructs.  The GLP-1R expression vector was constructed by subcloning 
PCR amplified human GLP-1R open reading frame into pcDNA 3.1 (Addgene). PCR 
amplification was carried out using a cDNA clone from GE Healthcare (CloneId: 
8327594, Accession: BC112126) as the template (forward primer, 5’ –
GGCCGGCCGCCCGCCATGGCCGGC-3’; reverse primer, 5’ –
GGAAGATCTTCCCCAGGGTCGGCTGCAGGAGGC-3’). The NK1R expression vector 
was constructed by subcloning PCR amplified human NK1R open reading frame into 
pcDNA 3.1 (Addgene). A cDNA clone from GE Healthcare (CloneID: 30915310, 
Accession: BC074912) was used as a template for the PCR amplification (forward 
primer, 5’-CGCCAAGCTTCACCATGGATAACGTCCTCCC-3’;  
reverse primer, 5’-CAAAGGCCGCGGGGCCAAGGAGAGCACATTGG-3’).  The 
constructs were verified by DNA sequencing (DNA Sequencing Facility, University of 
California, Berkeley).  
 
Immunocytochemistry.  Gastrointestinal tissues were from adult female (n=3) and male 
(n=3) C57BL/6 mice. Tissues were immersion-fixed for 1–2 days at 4°C. For cryostat 
sections, tissues were incubated in 20– 25% sucrose in PBS for 24 hr at 4°C, 
embedded in OCT compound (Miles), and sectioned at 10µm. Sections were processed 
after mounting on slides. Prior to immunostaining, tissue sections were incubated in an 
aqueous solution of 0.3 % Sudan black in 70% ethanol for 5min, rinsed and processed 
as previously described (62). Tissues were incubated with one of the following primary 
antibodies: GLP-1R, mouse 1:200 (71) Developmental Studies Hybridoma Bank, Iowa: 
substance P, rat 1:400 Cuello et al.(72); TRPV1, guinea pig 1:1000 Julius et al. (73); 
podoplanin, Syrian hamster 1:400 Farr et al. (74) Developmental Studies Hybridoma 
Bank, Iowa; LYVE-1 rabbit 1:200 (Abcam). Tissues were then washed and incubated 
with secondary antibodies conjugated to rabbit or goat anti rabbit, rat, mouse, or guinea 
pig IgG conjugated to FITC, Rhodamine Red X, Texas Red, or horseradish peroxidase 
(Jackson ImmunoResearch) or conjugated to Alexa-488 or Alexa-568 (Molecular 
Probes; 1:200 –1:1,500 dilution, at room temperature for 2 hr). For simultaneous 
detection of two antigens, specimens were incubated with primary antibodies against 
both antigens and then secondary antibodies labeled with contrasting fluorophores.  
Sections were then washed and mounted in ProLong Diamond Antifade Mountants 
(ThermoFisher) and then coverslipped. Non-specificity was assessed by analysis of 
staining by omission of primary antisera.  
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Confocal microscopy.  Specimens were observed using a Zeiss 710 laser scanning 
confocal microscope, or a Leica TCS-SP confocal microscope. The following objectives 
were used: Zeiss Fluar 20 (NA 1.0), Plan Apo 40 (NA 1.4), 100 (NA 1.3); Leica 10 (NA 
0.4), 20 (NA 0.7), 100 (NA 1.4). Images were collected at a zoom of 1–2 and typically 
10–20 optical sections were taken at intervals of 0.5–1.0 µm as previously described 
(75). Images were processed to adjust contrast and brightness using Adobe PhotoShop 
CS6 (Adobe Systems, Mountain View, CA) and digitally colored to represent the 
appropriate fluorophores (75). Images of stained and control slides were collected and 
processed identically.  
 
Structured illumination microscopy (SIM).  Imaging was performed in the Biological 
Imaging Facility at UCB using a Carl Zeiss Elyra PS.1 microscope with a 63x/1.4 and 
100x 1.47 objective lenses. Excitation wavelengths were 405, 488, 561, 642. Emission 
wavelengths were: 420-480; 495-550; 570-620; LP655. SIM processing and Channel 
alignment was done using ZEN Black, with 3D rendering, colocalization, and isosurface 
modeling using Imaris v9 (Oxford Instruments). Processing and filtering settings were 
kept constant and image intensity was preserved with the raw image scale option in 
Zen. Colocalization analysis was performed using Huygens Pro 18.10 (Scientific 
Volume Imaging B.V., The Netherlands) to generate a co-localization map using the 
Costes method of threshold estimation with Manders coefficients of X=0.833 and 
Y=0.465 Images presented are representative of a minimum of five fields viewed per 
replicate with at least two technical replicates and the experiment was conducted in at 
least three biological replicates. 
 
Mesenteric lymph fluid (MLF) extraction. MLF was extracted as previously described 
(62). Briefly, MLF was obtained from a cannula placed in the superior mesenteric 
lymphatic duct from isoflurane anesthetized and overnight fasted rats.  They were 
presented with 3 ml-bolus of either dextrin (1.1g in 3 ml 0.9 % NaCl representing fasted 
lymph) or lipid rich Ensure™ (representing fed lymph, Abbott Laboratories). Ensure™ is 
a mixed meal consisting of fat, carbohydrate and protein. Sixty min prior to the Ensure™ 
infusion, MLF was collected for fasted value. MLF was taken at various time points after 
Ensure™ was infused into the duodenum and placed on ice. MLF collected at 120 min 
after the nutrient infusion (at 1:50 dilution) induced the highest increase in [Ca2+]i 
mobilization in DRG neurons.  Therefore, we used this timing of collection to represent 
fed MLF.    
 
Cell culture condition and transfection. The non-tumorigenic rat mucosal epithelial cells 
(hBRIE 380i cells (76)) used for this study were as previously described (64).  They 
were well-characterized subclones expressing enterocyte phenotypes.  Experiments 
were performed using hBRIE 380i cells of passage 11-16.  Cells were maintained in 
Iscove’s modified Dulbecco’s medium (IMDM; gibco) with 10% bovine calf serum (BCS; 
Hyclone), 100 U/ml penicillin, and 100 g/ml streptomycin (Invitrogen) as additional 
supplements, at 37 °C in 5% CO2-95% air.  For experiments, cells were plated on 
circular optical borosilicate glass coverslips (18 mm, 0.13 to 0.17 mm; FisherScientific), 
coated with poly-L-Lysine (Sigma-Aldrich) and placed in 12 well plate at ~80% 
confluency on the day of use.  For transient transfection, cells were trypsinized, 
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resuspended in IMDM, and incubated with the plasmid DNA (3 µg plasmid DNA/1 
million cells) in a volume between 0.2 and 0.7 ml at RT for 5 min. Transfection was 
carried out by electroporation using Gene Pulser (Bio-Rad), in 0.4-mm cuvette at 0.25 
kV and 960 F.  Immediately after electroporation 1 mL of IMDM-10% BCS was added to 
the cuvette.  Cells were then plated on circular coverslips to reach ~80% confluency in 
16 hr.    
 
Neuronal cell culture and transfection. DRG were dissected and dispersed as previously 
described (77) with some modifications. DRG were removed from T1-T13, L1-L6, and 
S1-S4 segments of both sides of the spine from 4-8 weeks old mice. They were 
dissociated with 0.125% collagenase P (Boehringer) in CMF Hank’s solution (gibco) at 
37 °C for 40-60 min, pelleted (5 min at 750 x g) and resuspended in 0.25% trypsin 
(Invitrogen) at 37°C for 2 min. DRG were triturated gently with a fire-polished Pasteur 
pipette in culture medium (DMEM, gibco) with 5% Equine Serum (Hyclone), 5% FBS 
(Hyclone), 0.1 mg/ml penicillin– streptomycin (Invitrogen), 2 mM L-glutamine 
(Invitrogen), then centrifuged at 750 x g for 5 min using Eppendorf 5702 centrifuge. 
Cells were resuspended in culture medium and plated onto coverslips coated with poly-
L-lysin (PLL, Sigma-Aldrich). Cell cultures were maintained in a 5% (v/v) CO2 incubator 
at 37 °C. Transient transfections were carried out using Lipofectamine 2000 
(Invitrogen), following the provider’s protocols for neuronal cells grown at 60-80% 
confluency.  Cultures were examined 1–2 d after plating by Ca2+ microfluorimetry.   
 
 
Mouse primary DRG neurons-hBRIE 380i co-culture sensor system.  DRG neurons 
were co-cultured with hBRIE 380i cells transiently transfected with the NK1R receptor.  
The co-culture served in an assay that could be used to characterize GLP-1 and GIP 
sensory nerves for their functional phenotypes.  The hBRIE 380i cells, giving a SP like 
response, displayed no significant response to exendin-4 (Ex-4), GLP-1, GIP, capsaicin 
and AITC, and were grown under the DRG neuron culture conditions, were selected 
(sub-cloned).  These cells were transiently transfected to heterologously express NK1R 
and found to respond to SP starting at 0.5 nM and reaching a plateau at 100 nM. They 
were plated on the same glass coverslip as the DRG neurons about 16 hr post DRG 
dispersion and plating.  The co-culture was maintained in the DRG neuron culture 
medium at 37 °C in 5% CO2-95% air.  The hBRIE380i-NK1R cells could thus act as 
sensors to SP secretion from individual and adjacent neurons by displaying changes in 
intercellular calcium as measured by Fura-2 AM.  Approximately 40 hr after DRG 
neuron and 16 hrs after hBRIE380i-NK1R co-culture plating, cells were preloaded with 
Fura-2 AM and visualized by microscopy.  
 
Calcium mobilization assay.  Calcium imaging experiments where performed as 
previously described (62) with some modifications.  For Fura-2 AM measurement of 
[Ca2+]i mobilization, hBRIE 380i cells and DRG neurons were incubated at 37 °C in 
HBSS (gibco), 0.1% BSA (Hyclone), and 20 mM HEPES (gibco) at pH 7.4 for 50 – 60 
min.  Fura-2 AM (Invitrogen) was used at 2 µM and supplemented with 0.01% Pluronic 
F-127 (w/v, Invitrogen). Coverslips were washed 3 times with 1 x Ringers and were 
mounted in an open chamber at 37 °C. Fluorescence of individual cells were measured 
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at 340 and 380 nm excitation and 510 nm emission using a Nikon Diaphot microscope.  
Excitation and emission were controlled by Sutter instrument LAMBDA 10-2 (UV box), 
video camera (PIC-III, Sutter Instrument), and a video microscopy acquisition program 
(Imaging Workbench 5.2). Test substances were directly added to the chamber.  Each 
coverslip received a maximum of 6 sequential treatments, initiated with vehicle control, 
followed by an agonist of GLP-1R or GIPR, SP, CAP, AITC, and terminated with KCl or 
calcium. DRG neurons received a KCl (100 mM) treatment at termination of the 
experiment and hBRIE 380i cells received 10mM calcium at termination.  Post 
experimentally, neurons were selected based on their response to KCl using ANOVA 
followed by Tukey’s post hoc tests. They were identified as neurons if the average ratio 
during two 10-sec time intervals before the addition of KCl were above the number 
obtained using ANOVA followed by Tukey’s post hoc tests. Once identified, those 
neurons were further selected based on their response to specific treatments by the 
same statistical procedure. They were deemed to be a treatment responsive if the 
average ratio during two 10-sec time intervals before the addition of the stimulus was 
above the number obtained using ANOVA followed by Tukey’s post hoc tests. The 
same statistical procedure, ANOVA followed by Tukey’s post hoc tests, was employed 
when comparing different treatments.  Statistics were performed using Microsoft Excel.  
Statistical significance was assessed by one-way ANOVA, followed by Tukey’s post hoc 
test.  All graphs displaying Fura-2 AM ratios have been normalized to the baseline ratio 
F340/F380.   
 
Statistical analysis.  All statistical tests were performed using Microsoft Excel.  Values 
are reported as the mean ± SEM (where n = number of mice used) for [Ca2+]i 
mobilization imaging experiments where multiple independent days of imaging were 
performed.  A one-way single factor ANOVA followed by the Tukey’s post hoc tests and 
the Student’s t test (where appropriate) was used.  Efforts were made to ensure that 
equal numbers of mice of each genotype were used for each experiment (where 
appropriate), and that treatment and control groups were of identical and near-identical 
size and age.  Significance was labeled as follows: NS, not significant, p ≥ 0.05, *p < 
0.05, **p < 0.01, ***p < 0.001. 
 
 
 
Results  
The demonstration that MLF can induce increases in [Ca2+]i in TRPV1 expressing 
sensory neurons from primary cultured mouse DRG has led to the possibility that 
sensory nerves innervating the lacteals express receptors that are activated by 
molecules present in the MLF and IF. Because the content of the MLF is reflective of 
the composition of the diet present in the intestinal lumen, we explored for the 
expression of receptors for molecules in the MLF known to be dependent on the dietary 
state of the animal, in cells within the lacteal that could induce a sensory nerve 
response.  
 
GLP-1 and GIP are incretin hormones that have been established to be present in MLF 
in concentrations dependent on the fed state of the animal. SP has also been described 
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in neurons that innervate lymphatic vessels. We, therefore, examined the expression of 
GLP-1R on SP peptidergic nerves localized to areas exposed to IF as well as MLF. 
GLP-1R was found to be expressed in cells both in close and distal regions of the 
lacteals (Fig. 1A). GLP-1R and SP were found to co-localize in cells closely associated 
with lacteals. In contrast, cells of the sub-mucosa expressing SP were not found to 
express GLP-1R. TRPV1- and SP-immunoreactive cells were found in close association 
with the lymphatic endothelial marker LYVE-1 (Fig. 1B and C). GLP-1R was found in 
cells in close proximity or adjacent to LYVE-1 and within the podoplanin expressing 
tubular structure corresponding to endothelia of the villar lacteal (Fig. 1B and C, and 
Fig. 2A-D). Three -dimensional structured illumination microscopy (SIM) imaging of a 
lacteal rendered as a volume and isosurfaces was used to visualize structures of GLP-
1R on cells within the inner face of the lumen of the lacteal (Fig. 2A-D). Volumetric 
rendering of SIM images show that GLP-1R was positioned in between the podoplanin 
expressing outer surface of the luminal facing lymphatic endothelium and the central 
lacteal vessel expressing LYVE-1 (Fig. 2E-F), thus placing GLP-1R in the position to 
come in direct contact to MLF. This is consistent with the demonstration of GLP-1R 
expression on dendritic cells (78), immune cells of the gut (79) and of the innate 
immune system (80).  
 
Volume rendering of the SIM of villar lacteal endothelium and cells displaying TRPV1- 
and GLP-1R-immunoreactivity further revealed TRPV1 in cells within the lacteal (Fig. 
3A-C), with distinct population of cells within the lacteal expressing only GLP-1R or 
TRPV1, or expressing both receptors (Fig. 3D and E). The co-localization of TRPV1 and 
GLP-1 in cells within the lacteal indicated potential responsiveness of TRPV1 
expressing cells to GLP-1, such as those of the innate immune system as well as 
sensory nerves. 
 
The co-expression of GLP1-R and TRPV1 in cells within the lacteals led us to test 
whether sensory neurons would be responsive to MLF from fed animals. We tested the 
activation of mouse primary cultured DRG neurons in response to MLF from rats taken 
at various time points after lipid rich Ensure™ was instilled into the duodenum. Prior to 
the infusion, rats that were previously cannulated at the superior mesenteric lymphatic 
duct were fasted overnight. Sixty minutes prior to the bolus infusion, MLF was collected 
for fasted values (Fig. 4A). MLF (from both fed and fasted rats) transiently induced 
[Ca2+]i in about two thirds (63%) of total cultured DRG neurons (KCl sensitive) (Fig. 4B). 
Approximately one third (35%) of the neurons were MLF responsive sensory neurons, 
one third of which (12% of total neurons) were responsive to both capsaicin and AITC. 
Sensory neurons that were not responsive to MLF comprised 29% of the total neurons 
(Fig. 4B). We further explored if sensory neurons would show a differential response to 
MLF taken from pre- or postprandial animals. Sensory nerves exposed to MLF from 
fasted animals showed attenuated responses to capsaicin and AITC compared with 
when they were exposed to postprandial MLF (Fig. 4C). This indicates that MLF/IF can 
modulate sensory nerve response to TRPV1 and TRPA1 channel activating agents.  
 
Given dietary induced changes in lymph, we tested if GLP-1, as an incretin hormone 
present in postprandial lymph, could induce a transient [Ca2+]i increase in sensory 
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nerves. A potent GLP-1R agonist, Ex-4, at 50nM induced a transient increase in [Ca2+]i 
in primary cultured mouse DRG sensory neurons responsive to capsaicin and AITC 
(Fig. 5A). Fifty nine percent of cultured DRG neurons only responded to Ex-4 while 12% 
were both Ex-4 and capsaicin responsive (Fig. 5B). No transient increase in [Ca2+]i in 
response to Ex-4 in GLP-1R KO DRG neurons was observed. However, the DRG from 
GLP-1R KO animals contained more capsaicin responsive neurons than those from WT 
animals (55% vs. 38%) (Fig. 5B). 
 
Our immunocytochemical data showing population of cells co-expressing GLP1-R and 
SP led to the question if the downstream effector response of Ex-4 in cells co-
expressing GLP-1-and SP could result in the release of SP. In addition, TRPV1 and 
TRPA1 have been associated with the release of SP in gastric tissues and sensory 
neurons (81) (82).  To perform this study, we developed a functional assay to determine 
if GLP-1 stimulation of sensory neurons expressing TRPV1 and TRPA1 could directly 
result in the secretion of SP. 
 
The use of the DRG neurons as a model for GLP-1 induced activation of sensory 
nerves has a number of limitations when interpreting the results. One factor is that DRG 
neurons represent a highly heterogeneous group of neurons. Given the range of 
potential cell types expressing GLP-1R in the villus, it would be necessary to identify 
those cells whose downstream effector response, resulted from Ex-4-induced increases 
in transient [Ca2+]i, could lead to SP secretion. Studies measuring neuropeptide 
secretion from culture media of primary cultures of DRG neurons did not take into 
account the specific cell subtypes that release neuropeptides. In addition, the assay 
methodology was often not sufficiently sensitive to secretory products in the media 
whose concentrations fall below the detection threshold. Similarly, detection of transient 
changes in [Ca2+]i of a single sensory neuron does not directly translate to the secretion 
of peptides from that neuron.  
 
Therefore, we developed a system whereby non-tumorigenic rat mucosal epithelial cells 
(hBRIE 380i cells ) transfected to heterologously express the SP NK1R could be 
cultured with primary dispersed mouse DRG neurons. These hBRIE 380i-NK1R cells 
could act as SP sensors that would respond to the SP released from individual and 
adjacent neurons by displaying changes in [Ca2+]i (measured using Fura-2 AM) (Fig. 6). 
Non-tumorigenic hBRIE 380i cells that displayed no endogenous responses to Ex-4, 
GLP-1, GIP, capsaicin, AITC, and SP (Fig. 6A) were selected (subcloned) to grow 
under DRG neurons culture conditions. These cells were transiently transfected to 
heterologously express NK1R and found to respond to SP starting at 0.5nM and 
approaching a plateau at 100nM (Fig. 6B). Dispersed DRG and hBRIE 380i-NK1R co-
cultures were preloaded with Fura-2 AM and visualized by microscopy for changes in 
[Ca2+]i in response to a variety of stimulants. Fig. 6D-F is a representative response plot 
using the SP sensor bioassay. Transient increase in [Ca2+]i in response to 50nM Ex-4 
was found in both nerves responsive to AITC and capsaicin that also resulted in SP-
sensor response (SPR) (Fig. 6F). These transient increases in [Ca2+]i were also found in 
neurons that did not display SPR (Fig. 6F) indicating that GLP-1 has effects on 
peptidergic sensory and non-sensory neurons. The Ex-4 induced SPR suggests that a 
 16  
number of GLP-1 effects could be mediated through SP and other neuropeptides 
secreted from sensory neurons.  
 
 
Ex-4 induced a transient increase in [Ca2+]i in DRG sensory neurons. A significant 
increase in the SPR was observed in sensors adjacent to those neurons (Fig. 7A). 
Consistent with the observations of the increased number of DRG sensory neurons 
responding to capsaicin from the GLP-1R KO animals, we observed an enhancement of 
the transient increase in [Ca2+]i corresponding to increases in SPR with capsaicin 
treatment in GLP-R KO neurons (Fig. 7B). This suggests that GLP-1 attenuates 
capsaicin induced neuropeptide secretion. This is consistent with the increase in SPR to 
Ex-4 that was observed in TRPV1 KO DRG neurons (Fig. 8A). However, attenuation of 
the transient increase in [Ca2+]i in DRG neurons that also parallels attenuation in SP 
secretion in the presence of Ex-4 remains in the TRPA1 KO DRG neurons (Fig. 8B). No 
significant difference in the transient increase in [Ca2+]i was observed in DRG neurons 
[Ca2+]i response or in the SP-sensor response in sensory neurons from TRPA1/TRPV1 
double KO animals. Thus Ex-4 induced SP secretion is dependent on the expression of 
either or both the TRPA1 and TRPV1 channels. (Fig. 9). 
 
Given that GIP is also an incretin that has been found in postprandial MLF, we 
examined if GIP, like GLP-1, could also result in a SPR. GIP responsive neurons were 
found to induce SP secretion from GIP responsive neurons (Fig. 10). However unlike 
GLP-1, GIP was found to enhance rather than attenuate capsaicin induced SP release 
from peptidergic sensory neurons. 
 
Discussion  
In these studies, we present a pathway whereby the contents of the IF can be 
monitored by the peripheral tissues and central nervous system (CNS) through the 
sensory nerves associated with the lymphatic vasculature. These sensory nerves 
represent an extra-vagal route for the CNS to respond to molecules, present in the IF 
and associated with tissue ECM, through local lymphatic vessels. Traditionally the 
lymphatic system has been viewed as a passive network of capillaries and collecting 
vessels that plays a critical role in maintaining interstitial pressure, the transport of 
molecules such as lipids, antigen presentation, and returning plasma extravasated 
proteins to the circulation (83) (84).  
 
Recent attention has been given to the secretory products of cells that comprise the IF 
for their potential ability to initiate biological responses, such as immune function and 
tumor growth. The composition of the MLF is a reflection of interstitial fluid and is 
subject to similar endogenous determinates, such as hydrostatic pressure and 
transcapillary exchange of proteins in the blood (43). Additionally, MLF is composed of 
molecules from exogenous sources, such as from diet in the intestinal lumen. Molecules 
of the IF could both be monitored by the CNS and have their biological activity 
coordinated to yield physiological responses through peripheral sensory nerves. The 
lymphatic microvasculature provides a point of convergence for molecules from local 
pools of IF, to activate sensory nerves associated with those vessels or capillaries.  
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The characterization of the lysophosphatidic acid receptor LPA5 provided evidence that 
receptors on sensory nerves were responsive to dietary induced changes of lymph/IF 
contents, and brought forth a mechanism for direct activation of primary sensory 
neurons in response to intestinal contents and the subsequent release and 
accumulation of peptides into the IF/MLF (63) (64).  This led to the possibility that 
GPCRs, like LPA5, expressed in sensory nerves and found in peripheral lymphatic 
vessels could also perform a similar function in response to molecules in the lymphatic 
fluid derived from the interstitium. Additionally, the transient increase in [Ca2+]i observed 
in response to MLF was dependent on the fed state of the animal which indicates that 
the composition of MLF/IF is also a reflection of exogenous sources, such as from the 
intestinal lumen. Similar to the mucosal lacteals, the medial layer of peripheral lymphatic 
vessel walls is also richly innervated with SP-, CGRP- and other peptide-containing 
nerves (85) (86). Therefore, sensory nerves of the lymphatic vasculature could provide 
a conduit for the afferent signaling of bioactive molecules in IF accumulated in the 
mesenteric lymph vessels through the proposed neurolymphocrine system (62). This is 
exemplified in the diet dependent induction of the transient increases in [Ca2+]i that we 
observed in the sensory nerves responsive to capsaicin and AITC upon exposure to 
MLF.  
It was previously reported that GLP-1 did not induce transient increases in [Ca2+]i in 
primary cultured DRG sensory neurons (87). In that study capsaicin sensitivity was not 
affected by acute treatment with 100 nM of Ex-4 or GLP-1, compared to controls (12 
neurons). Enhanced ATP signaling in the presence of Ex-4 led to the conclusion that 
nociceptive capsaicin / heat pain receptor TRPV1 was not affected by acute application 
of GLP-1, that was taken as an indication that the GLP-1R did not participate in 
signaling involving TRPV1 (87). 
However, in our study we observed significant transient increases in [Ca2+]i in response 
to both GLP-1R and GIP-R activation, which is consistent with the transient increases in 
[Ca2+]i mediated by Gαq pathways, and by Gαs, observed for insulin induced secretion 
by activation of GLP-1R (88-91). This exemplifies the importance of linking signaling 
pathways in the context of a functional effector response. This is especially true for the 
B family GPCR's, such as GLP-1R and GIPR, which can be pleiotropically coupled with 
multiple signaling pathways important for receptor function (92). 
 
Conclusions derived from studies using primary culture DRG models need to take into 
consideration in vitro conditions that are bias for particular subpopulations compared to 
the heterogeneity of DRG neurons in vivo. For example, neuron populations in culture 
can be induced to become peptidergic in the presence of nerve growth factor (93). The 
labeling of specific subpopulations of DRG, and determining their corresponding 
function remains challenging. Efforts have been made to determine molecular markers 
and the transcriptional profiles of DRG neurons, both at whole population and single cell 
levels in an effort to determine their modality and their activators (94). This has allowed 
the identification of a greater number of DRG neurons beyond the general classification 
of nerve fiber subtypes (Aα, Aβ, Aδ and C fibers) (95). In our study, we characterized 
DRG neurons based on their ability to secrete SP in response to GLP-1 and GIP, thus, 
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establishing a functional phenotype for cell subpopulations. The co-culture sensing 
system allowed us to examine subpopulations of DRG neurons that when activated by 
GLP-1 and GIP induce a transient increase in [Ca2+]i that results in SP release. These 
cells can be contrasted to those subpopulations of neurons that responded to GLP-1 
and GIP with a transient increase in [Ca2+]i which do not result in SP release. The 
characterization of these subpopulations of neurons could elucidate further biological 
effects of incretins on non-peptidergic neurons. 
 
Both TRPV1 and TRPA1 are members of a subset of transient receptor potential (TRP) 
proteins which belong to the superfamily of cation channels that have central roles as 
noxious and chemo sensors (96). The expression of TRPV1 in cells adjacent to and 
within the lacteals, such as macrophages, neutrophils, and mast cells (70), and sensory 
nerves associated with lacteals, positions these cells as potential signal transducers 
that respond to chemical stimuli from the IF of local tissue pools. 
The release of SP from gastrointestinal tissues has been closely correlated to the 
expression and activation of TRPV1 and TRPA1 from cells of those tissues (81,82,97). 
Our demonstration that Ex-4 induced SP secretion is blocked only in TRPV1 and 
TRPA1 double KO neurons supports the suggestion that TRPA1 and TRPV1 co-
expression on DRG neurons could lead to the 2 channels interacting and modulating 
each other’s activities (55). This might be exemplified by an accumulated transient 
increase of [Ca2+]i leading to SP secretion. This regulation could have significance 
physiological importance for GLP-1 as a modulator of TRP proteins on peptidergic 
neurons such as those that secrete SP.  
SP has a wide range of activities from acting in neuromodulation, neuronal integrity, 
sensory perception, and pain, to regulation of movement, respiration, inflammation and 
depression (98). GIPR and GLP-1R induced increases in [Ca2+]i in sensory nerves 
result in release of SP from individual nerves is of particular interest because SP shares 
many biological effects with GLP-1 amide which includes vasodilation (99,100), cell 
growth (101,102), and pancreatic neuroprotection (103,104) (105). This raises the 
likelihood of synergy between GIP/GLP-1 and SP on end organ response, for example, 
the modulation of inflammatory responses and blood pressure. 
 
Our data suggest that GLP-1, by itself, could act as an inflammatory mediator by 
activating sensory nerves via TRPV1 and/or TRPA1 to release SP. However, under 
conditions where sensory neurons are presented to GLP-1 prior to capsaicin 
stimulation, the capsaicin-induced inflammatory response resulting in SP release is 
attenuated. This supports not only an interplay between TRPV1 and TRIPA1 on [Ca2+]i 
and nociceptor function(106,107), but also modulation of that interplay by factors whose 
concentrations fluctuate in the IF/MLF such as GLP-1 
 
The activation of NK1R by SP could be a pathway for TRPV1 to induce inflammation. 
Both pro and anti-inflammatory effects of GLP-1 have been described to be tissue 
specific (91). GLP-1 can inhibit the recruitment and activation of macrophages, and 
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reduce the release of pro-inflammatory mediators in monocytes (108). However, in the 
brain, the presence of GLP-1R results in increased IL-6 expression (109), indicating a 
potential pro-inflammatory effect. 
 
Our data indicate that the degree of GLP-1 induced SP release is dependent on the 
timing and exposure of GLP1 on sensory nerves expressing TRPV1 and/or TRPA1 
channels. In mouse primary cultured DRG neurons, GLP1 induces SP release in both 
TRPV1 and TRPA1 expressing neurons independent of capsaicin and AITC. Capsaicin 
and AITC alone induce SP release that is significantly elevated over that of GLP-1 
alone. However, the prior exposure of GLP-1 on neurons significantly attenuates the 
levels of released SP in response to subsequent exposure to capsaicin.  This 
attenuation of SP release was not observed with DRG neurons similarly treated with 
AITC, which could indicate independent inhibitory pathways initiated by GLP-1R 
activation of TRPV1 that is not linked to TRPA1. However, DRG neurons from TRPV1 
and TRPA1 double KO mice did not display Ex-4 induced SP secretion, thus, indicating 
a shared signaling pathways that leads to the release of SP. SP secretion resulting from 
GLP-1/GIP activation of sensory nerves could provide a pathway for molecules found in 
the IF and/or lacteals to modulate the innate immune function or inflammation in 
response to diet dependent signals. 
 
SP is present in all peripheral sensory nerves particularly those associated with blood 
vessels. Activation of NK1 has been shown to induce vasodilation and reduce blood 
pressure (110). GLP-1 has also been shown to increase blood flow and decrease blood 
pressure. GLP-1 has been implicated in having a direct effect in vasodilation via 
endothelial nitric oxide synthase (111). The blood pressure lowering effects have been 
observed in mouse models of hypertension (112). The potential modulation of blood 
vessel dilation by GLP-1, through the release of SP sensory nerves associated with 
blood vessels, expands the mode of action of GLP-1 as having a “local effector 
function.” A term first used for peripheral endings of afferent nerves and the adjacent 
tissues that organize immediate response to stimuli (110). In our model the dietary 
induced release of GLP-1, resulting in its accumulation in the MLF and IF, would induce 
vasodilation and increase blood flow via SP release from sensory nerves in close 
association with capillary endothelium. This would be independent of its role on 
glycemic control yet modulated by dietary intake. 
 
Apart from our newly described effects of GLP-1 and GIP via the release of SP from 
sensory neurons, our study further broadens the mode of action as of GLP-1 and GIP 
as incretins. While the activation of afferent nerves by GLP-1 and GIP has significant 
effects on pancreatic response through canonical pathways such as vagal afferents, its 
effects on the pancreas and islet responses could also be exerted through sensory 
pathways involving spinal nerves. Classically, neuro modulation of pancreatic 
responses is through vagal afferent neurons. However, it has been reported that up to 
70% of retrogradely labeled small to medium pancreatic primary afferent neurons (in 
both the thoracolumbar DRG and the nodose ganglia) show TRPV1 immunoreactivity 
(113).  Hence, the majority of pancreatic primary sensory neurons express TRPV1. It 
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has been demonstrated that sensory nerves of the DRG, such as those containing 
calcitonin gene related peptide (CGRP), have cell bodies that project to the distal 
intestine (114). Thus, MLF induced local release of SP from sensory neurons of DRG 
suggests the potential of a similar pathway whereby GLP-1 and GIP from lacteals could 
exert their effects on sensory nerves of pancreatic islets through canonical pathways, 
such as vagal afferents, as well as sensory pathways involving spinal nerves and the 
CNS (115) in response to exogenous and endogenous stimuli.  
 
 
The presence of GLP-1 and GIP in the ML/IF and their induced release of SP expand 
the effector response of these incretin hormones through the sensory nerve secretion of 
SP. The mode of action of GLP-1 and GIP via SP from sensory neurons is not likely 
confined the release of this neuropeptide. At least 12 neuropeptides have been reported 
to be present in TRPV1 positive sensory neurons (61,116). These include somatostatin, 
vasoactive intestinal polypeptide, cholecystokinin, galanin and corticotrophin-releasing 
factor, all of which have established systemic effects. The proposition that multiple 
neuropeptides can be simultaneously released from TRPV1 activated sensory nerves 
further expands the potential mode of action of GLP-1 and GIP beyond the effects of 
SP. The local MLF/IF induced neuropeptides release from sensory nerves suggests the 
likelihood of a shared pathway for molecules found in the IF and MLF, such as GLP-1 
and GIP, that can exert their effects on peripheral tissues as well as the CNS (115) in a 
pathway autonomous of the vascular circulation through a neurolymphocrine system. 
  
 
 
 
 
 
 
Figures and Legends:
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Fig. 1.  
 
Immunocytochemical localization of GLP-1R, SP and TRPV1 in mouse distal 
small-intestinal lacteals and in nerve fibers. A: A low magnification confocal image 
montage of microvilli demonstrating GLP-1R (red, rhodamine labeled) on cells along the 
length of mucosal villus (arrows a). GLP-1R and SP (green, FITC labeled) cells were 
found to co-localize in the mid villar region (yellow, arrows c), in contrast to the 
submucosa where SP was detected in nerve fibers void of GLP-1R (arrows b).  B: 
TRPV1 (arrow a) was found in cells in regions along the center of the villus in proximity 
to LYVE-1 (arrow b) of the lacteal endothelia. C: SP (arrows a) was observed in close 
association with LYVE-1 of the lymphatic endothelia. DAPI-stained nuclei are blue. The 
Object Pearson and Manders co-localization were determined using HuygensPro 
software.
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Fig. 2.  
 
Immunocytochemical localization of GLP-1R within the inner luminal surface of 
the villar lacteal endothelium. A and B: Maximum intensity projection villar LYVE-1 
(rhodamine) is shown localized primarily to an inner central area of the lacteal 
endothelium (arrow a) compared to the pattern of expression of GLP-1R (FITC, arrow 
b). C: 3D-SIM imaging of a lacteal rendered as a volume (Imaris). Isosurfaces were 
used to visualize structures of GLP-1R (red, rhodamine) cells (arrows a,b,c) surrounded 
by podoplanin endothelium (green, FITC). D: Rotational projection shows GLP-1R on 
cell surfaces (arrows a,b,c) within the lacteal endothelial tubular structure forming the 
lacteal outlined by podoplanin. E: Confocal microscopy imaging of a mucosal villus 
demonstrating differential distribution of podoplanin (arrow a) and LYVE-1 (arrow b) on 
the lacteal endothelium. F: Volumetric rendering of SIM images show expression of the 
endothelial markers (arrows a,b) in a diffuse pattern of podoplanin on the outer surface 
of the endothelium (arrow a) while LYVE-1 is distributed as in a more confined area 
within the central region within the lacteal (arrow b). Images are representative of a 
minimum of five fields viewed of a minimum of 5 replicate samples of tissue sections per 
animal (n=6) with at least two technical replicates per set of samples.
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Fig. 3.  
 
Volume rendering of SIM of villar lacteal endothelium and cells displaying TRPV1 
and GLP-1R. A-C: Rotated projections of SIM image stack from panel A are displayed 
in panels B and C. Isosurface renderings of structures showing lacteal with TRPV1 
(rhodamine) cells (arrows a,b,c) surrounded by podoplanin endothelium (FITC). 
Projection in panel B shows cells (arrows a,b,c) of panel A with no podoplanin covering 
the outer surface of the cells from the inner (luminal) side of the lacteal vessels. C: 180° 
rotation of isosurface rendered in panel B revealed masking of TRPV1 fluorescence on 
cells (arrows a,b,c) by podoplanin indicating cells lie within the lacteal endothelial 
vessel. D: Maximum intensity projection of GLP-1R (green, FITC) in cells that were 
found to be adjacent (arrow a) to cells displaying TRPV1 (arrow b) or to co-localize 
(arrow c) with cells expressing TRPV1 (arrows c). E: is a similar projection of cells 
(arrows a,b,c) from panel D showing the same relationship. Images are representative 
of a minimum of five fields viewed per replicate with at least two technical replicates and 
the experiment was conducted in at least three biological replicates. 
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Fig. 4.  
 
Mesenteric lymphatic fluid  induces a transient increase in [Ca2+]i in primary 
cultured mouse dorsal root ganglia (DRG) neurons. A: Time line used for Fura-2 AM 
calcium imaging assay depicting the approximate time intervals (about every 100 sec 
apart) with the respective treatments, vehicle control (VC, 1x Ringers), followed by fed 
and/or fasted MLF (at 120 min after food intake for fed, 0 min for fasted), capsaicin 
(Cap, 1μM), allyl isothiocyanate (AITC, 1μM) and KCl (100mM). B: [Ca2+]i assay was 
done on mouse primary cultured DRG neurons as described in figure 6. They were 
exposed to total MLF (1:50 dilution) taken from fed and fasted rats combined (n=3). 
Sixty-three percent of the total neurons responded to MLF, 28% were not sensory 
nerves. Seventeen percent and 6% of the MLF responsive neurons were sensory, Cap 
and AITC, respectively. Sub-populations of non-MLF responsive neurons were only 
responsive to Cap (8 %) or AITC (18 %).  A similar percentage of neurons respond to 
either Cap or AITC, 40% and 39%, respectively. C: Cultured DRG neurons presented 
with lymph from fasted animals, ( )  showed attenuation in the transient increases in 
[Ca2+]i in response to both Cap and AITC compared to lymph from fed animals ( ). Bars 
are means SE (n=3). NS, not significant, p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. 
  
 29  
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 100 200 300 400 500 600 700 800
Time (s)
FR
 (3
40
/3
80
 n
m
)
VC Ex-4 Cap AITC KClA
B
18 Neurons
(26%)
41 Neurons
(59%) 8 Neurons(12%)
52 Neurons
(55%)
WT GLP-1R KO
Ex-4
CapCap
 30  
Fig. 5.  
 
Ex-4 induces a transient increase in [Ca2+]i in primary cultured DRG neurons. A: 
Tracing of a single mouse primary cultured DRG neuron treated sequentially with VC 
(1x Ringers), 50 nM Ex-4, Cap, AITC, and KCl; as described in Fig. 4. B: The Venn 
diagram depicts a higher percentage of neurons responding to only Cap treatment in 
the GLP-1R KO compared to WT. Approximately half of the neurons responded to both 
Cap and Ex-4 in the WT animals.  
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Fig. 6.  
 
The DRG neurons and hBRIE 380i cells co-culture bioassay for determining a SP 
functional phenotype of individual sensory nerves. A: hBRIE 380i cell subclones did 
not show an increase in [Ca2+]i in response to either Ex-4 (50 nm), GLP-1 (50 nm), GIP 
(50 nm), AITC (1uM), or Cap (1uM), or to SP (250 nM), black bars ( ) compared with 
the vehicle control (VC). Bars are means ± SE (n=3). NS, not significant, p ≥ 0.05, *p < 
0.05, **p < 0.01, ***p < 0.001. B: The hBRIE 380i cells heterologously expressing the 
NK1R receptor were stimulated using different concentrations of SP. The SP-sensors 
responded to SP in a range from 0.5 nM to 250 nM. Bars are means ± SE (n=3).  NS, 
not significant, p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001.  C: Diagram illustrating 
sensor cell model. (1) Dispersed DRG neurons were plated on 18 mm round 
borosilicate glass coverslips and co-cultured with SP sensors. Fifty to sixty min prior to 
microscopy, cells were loaded with 2 uM Fura-2 AM. After preloading with Fura-2 AM, 
cultured cells were treated with vehicle control (VC) followed by Ex-4 and lastly with SP 
to identify sensor cells, Cap to identify cells expressing transient receptor TRPV1, AITC 
to identify cells with TRPA1, and KCl to identify nerves. Activation was determined by 
changes in intracellular calcium (2 and 3). Sensor cells (2) were activated by secreted 
SP from adjacent nerves. D and F: Example of the bioassay for SP secreted from single 
neurons using the co culture of neuronal cells with SP sensor cells. Cell 1 was a neuron 
(KCl responsive) that released SP in response to Ex-4 expressing both TRPA1 and 
TRPV1 channels. The SP response was detected by sensor cell 2 in the presence of 
Ex-4 (red). Cell 3 was a nerve that responded to Ex-4, but did not release SP as 
indicated by sensor cell 4, and was not responsive to TRPA1 and TRPV1 agonists. Cell 
5 was a non-transfected hBRIE 380i cell.  E: The range of detection in the transient 
[Ca2+]i depicted calorimetrically for in the DRG neurons (panel 1) and SP-sensors (panel 
2) when treated with Ex-4 and SP. 
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Fig. 7.  
 
Ex-4 treatment of DRG neurons significantly induces release of SP, and 
attenuates SP release in response to Cap. Mouse primary cultured DRG neurons 
from WT ( ) and GLP-1R KO ( ) animals were co-cultured with SP-sensors ( ) and 
exposed to 50 nM Ex-4, followed by Cap and KCl. Concentrations of the treatments 
were as described in Fig. 6. For GLP-1R rescue, DRG from GLP-1R KO animals were 
transiently transfected with GLP-1R. A: Ex-4 induced a significant transient increase in 
the [Ca2+]i in the WT ( ), but not in GLP-1R KO ( ). The sensor response corresponded 
to the DRG neuron calcium response, showing significance in the WT and no 
significance in the GLP-1R KO.  B: Cap, in the presence of Ex-4, significantly stimulated 
SP response in the WT and GLP-1R KO rescue ( ) but not in the GLP-1R KO. NS, not 
significant, p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. 
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Fig. 8.  
 
Ex-4 induced SP release from DRG neurons occurs in sensory neurons that 
express TRPV1 or TRPA1 channels. DRG from TRPV1 KO (A) and TRPA1 KO (B) 
animals were co-cultured with SP sensors ( ) and exposed to 50 nM Ex-4, followed by 
Cap, AITC, and KCl. Concentrations of the treatments were as described in Fig.6. A:  
TRPV1 KO neurons ( ) still produces a significant increase in Ex-4 calcium response 
and also a corresponding SP-sensor ( ) response. Cap treatment, however, does not 
result in significant difference in either DRG neurons or SP-sensor [Ca2+]i.  An 
attenuation in the transient increase in the [Ca2+]i  of DRG neurons calcium, but not in 
SP, is observed with AITC treatment. B:  TRPA1 KO neurons ( ) also show a transient 
increase in the [Ca2+]i in response to Ex-4 which corresponds to SP secretion( ).  
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Fig. 9.  
 
Ex-4 induced SP release does not occur in sensory neurons from TRPA1/TRPV1 
double KO DRG. Mouse primary cultured DRG neurons ( ) from TRPA1/TRPV1 
double KO animals were co-cultured with SP-sensors ( ) and exposed to 50 nM Ex-4, 
followed by Cap, AITC and KCl. Concentrations of the treatments were as described in 
Fig. 6.   
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Fig. 10.  
 
GIP induces SP release from capsaicin responsive DRG sensory neurons. The 
graph depicts SP-sensor ( ) response.  Mouse primary cultured DRG neurons from WT 
and GIP KO animals were co-cultured with SP sensors and exposed to 50 nM GIP.  GIP 
induced an increased calcium response in SP-sensors adjacent to Cap responsive 
sensory neurons in DRGs from WT animals ( ) but not from GIP KO animals.  GIP was 
found to enhance the Cap induced substance P secretion. NS, not significant, p ≥ 0.05, 
*p < 0.05, **p < 0.01, ***p < 0.001.   
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Summary and Future Study  
The results of these experiments provide an extra-vagal pathway in which the peripheral 
tissues of the body and the CNS can sense IF contents via sensory nerves that 
innervate the lumen of the lymphatic vasculature.  This pathway expands the function 
and effector response of GLP-1 and GIP as model molecules in the MLF/IF whose 
concentration is diet dependent.  The extra hormonal and extra pancreatic action of 
GLP-1 and GIP can now include their ability to induce by the secretion of SP from 
primary cultured DRG neurons.  In addition, it can be speculated that other 
neuropeptides, beside SP, are released in such stimulation, as it is known from the 
literature that TRPV1 expressing sensory neurons also contain other neuropeptides.  
Through these findings, it could be suggested that GLP-1, GIP and potentially other 
bioactive molecules in the MLF/IF could have effects on the peripheral tissue and the 
CNS though these neuropeptides, whose activation and secretion is controlled by their 
surrounding MLF/IF.   
 
The investigation of this chemosensory system of the interstitium has opened doors to 
questions that remain to be answered.  First and foremost is the question of lacteal 
innervation by sensory nerves of the DRG.  To add evidence obtained through antibody 
staining, retrograde and /or anterograde tracing could be used to determine that spinal 
nerves enter the lumen of the lacteals.  This will allow us to follow the nerves from the 
lacteals to the DRG, or DRG to epithelium of the lacteal. Other future experiments may 
include the investigation to:  1) determine the expression and localization of receptors 
for nutrient responsive peptides on sensory nerves, such as CCK-AR and PYY, 2) 
determine if activation of these receptors induce the release of neuropeptides, such as 
SP, CGRP, somatostatin, vasoactive intestinal polypeptide, etc., and 3) determine 
response of systemic lymph and compare/contrast to mesenteric lymph.  The results of 
these suggested future studies could provide us a clear pathway whereby a specific 
organ can directly communicate with the CNS through its local lymph/IF and regulate an 
essential physiological function.   
 
*The sections Methods, Results, and Discussion in this dissertation were originally 
prepared for a manuscript to be submitted for publication with my adviser as the 
corresponding author 
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